Skip to main content

Advertisement

Log in

Anakinra for Treatment of Liver Abscesses in a Patient with a Novel CYBB Variant of Chronic Granulomatous Disease

  • Letter to Editor
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Rosenzweig SD. Inflammatory manifestations in chronic granulomatous disease (CGD). J Clin Immunol. 2008;28:S67–72.

    Article  Google Scholar 

  2. Straughan DM, McLoughlin KC, Mullinax JE, et al. The changing paradigm of management of liver abscesses in chronic granulomatous disease. Clin Infect Dis. 2018;66:1427–34.

    Article  CAS  Google Scholar 

  3. Hussain N, Feld JJ, Kleiner DE, Hoofnagle JH, Garcia-Eulate R, Ahlawat S, et al. Hepatic abnormalities in patients with chronic granulomatous disease. Hepatology. 2007;45:675–83.

    Article  Google Scholar 

  4. Kobayashi SD, Voyich JM, Braughton KR, Whitney AR, Nauseef WM, Malech HL, et al. Gene expression profiling provides insight into the pathophysiology of chronic granulomatous disease. J Immunol. 2004;172:636–43.

    Article  CAS  Google Scholar 

  5. de Luca A, Smeekens SP, Casagrande A, Iannitti R, Conway KL, Gresnigt MS, et al. IL-1 receptor blockade restores autophagy and reduces inflammation in chronic granulomatous disease in mice and in humans. PNAS. 2014;111:3526–31.

    Article  Google Scholar 

  6. Hahn KJ, Ho N, Yockey L, Kreuzberg S, Daub J, Rump A, et al. Treatment with anakinra, a recombinant IL-1 receptor antagonist, unlikely to induce lasting remission in patients with CGD colitis. Am J Gastroenterol. 2015;110:938–9.

    Article  CAS  Google Scholar 

  7. Uzel G, Orange JS, Poliak N, Marciano BE, Heller T, Holland SM. Complications of tumor necrosis factor-α blockade in chronic granulomatous disease—related colitis. Clin Infect Dis. 2010;51:1429–34.

    Article  Google Scholar 

Download references

Availability of Data and Material

From patient’s clinical record

Code Availability

MS Office 365, licensed to Queensland Health

Author information

Authors and Affiliations

Authors

Contributions

CT and LD were involved in the clinical care of the patient and wrote the article. AW was involved in the genetic testing of the patient and family members. All authors have given their approval of the manuscript.

Corresponding author

Correspondence to Caroline To.

Ethics declarations

Conflict of Interest

The authors declare no competing interests.

Statement of Informed Consent

The patient has provided written informed consent for the publication of this case report including the images.

Ethics Approval

Not applicable.

Consent to Participate

See above under “Statement of Informed Consent”.

Consent for Publication

Refer also to “Statement of Informed Consent” above. The patient and their family have consented to the submission of the case report to the Journal, including publishing their data and results.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

ESM 1

(DOCX 3976 kb)

ESM 2

(PDF 797 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

To, C., Williams, A. & Droney, L. Anakinra for Treatment of Liver Abscesses in a Patient with a Novel CYBB Variant of Chronic Granulomatous Disease. J Clin Immunol 41, 1368–1371 (2021). https://doi.org/10.1007/s10875-021-01028-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10875-021-01028-0

Navigation